1, 7,8 Novo Nordisk has filed for a label update of Wegovy in the US and EU to include an indication for risk reduction of major adverse cardiovascular events in adults with a BMI of 27 kg/m 2 and established cardiovascular disease
Rosenstock J, Del Prato S, Franco DR, Vazquez LA, Dai B, Weerakkody GJ, Fernandez LA, Rodriguez A, Bergman B
When the dose goes up little by little, people can better see how their body responds and find the right maintenance dose without putting too much pressure on the system
Wootten D, Reynolds CA, Smith KJ, Mobarec JC, Koole C, Savage EE, et al
If any part of your label is unclear, call your pharmacy before injecting